Skip to main content
Philosophical Transactions of the Royal Society B: Biological Sciences logoLink to Philosophical Transactions of the Royal Society B: Biological Sciences
. 2025 Sep 4;380(1934):20240064. doi: 10.1098/rstb.2024.0064

Preface: the ecology and evolution of bacterial immune systems

Edze Rients Westra 1,, Uri Gophna 2, Stineke van Houte 1
PMCID: PMC12409348  PMID: 40904113

The constant exposure of bacteria to viral parasites, known as bacteriophages (phages), has driven the evolution of a huge number of bacterial immune mechanisms that can protect against these infections. Over the past decade, the landscape of bacterial immunity has been radically transformed by a surge of discoveries. These have revealed an astonishing diversity of defensive mechanisms, many of which operate via entirely novel molecular principles. Interestingly, as discussed in a perspective by Barthes et al. [1] in this Discussion Meeting issue, many of these immune strategies are ancient and in some cases conserved across domains of life. Their discovery and characterization therefore help us to identify general principles of host defence against viral infections.

Though our understanding of the mechanisms, ecology and evolution of immune systems is progressing, we are still facing numerous unanswered questions. This issue brings together researchers from across disciplines to address some of these questions. Contributions range from comparative genomics and structural biology to experimental evolution and environmental ecology, all aimed at illuminating the principles that govern immune system diversity, function and evolution. By uniting these diverse perspectives, we hope to foster a more integrated understanding of how bacteria defend themselves against viral predators, and how such defence mechanisms are shaped by the environments in which they evolve.

The issue covers the following areas. First, a number of contributions address gaps in our mechanistic understanding of immune systems. For many defence strategies, we still lack answers to some of the most fundamental questions: How are immune responses regulated? What are the molecular sensors that detect phage infection and initiate the immune response? What specific molecular features, such as modified bases in viral DNA or host functionalities that are essential for phage replication, do these systems recognize and target? And once a response has successfully been launched, how does the system ‘reset’ after the infection has been cleared? Here, Koonce et al. [2] describe the identification of regulators of the CRISPR-Cas immune system of Pseudomonas aeruginosa, while Readshaw et al. [3] and Belukhina et al. [4] identify the targets of type IV restriction–modification (RM) and PARIS immune systems, respectively, and Hoikkala et al. [5] describe the identification and distribution of enzymes involved in the deactivation of the type III CRISPR-Cas immune system.

Second, we have an incomplete understanding of the phenotypes that immune systems produce. Some systems, like RM, cleave the phage genome, whereas other systems, such as CBASS, are thought to trigger cell death or dormancy. These phenotypes may vary depending on the genetic background of the host bacterium, the nature of the infecting phage and the presence or absence of other immune systems. In this theme issue, Clabby et al. [6] present a perspective on the mechanisms that may drive defence co-occurrence within bacterial genomes, and the potential redundancy, synergy or division of labour between different systems. Kupczok et al. [7] describe computational methods to link bacterial genotypes to phage resistance phenotypes, and Pons et al. [8] present single-cell analysis of bacteria with either CRISPR immunity or receptor mutations, to identify genotype–phenotype links at a resolution not achievable in bulk assays. David et al. [9] experimentally examine how different defence systems of Escherichia coli isolates contribute to their resistance profile against phage infections, using systematic knock-outs of different defence systems, whereas Czernuszka et al. [10] examine how the number of defence systems per genome predicts the infectivity/resistance profile of phage cocktails against a large panel of clinical P. aeruginosa isolates.

Third, we know surprisingly little about how different defences are distributed across ecosystems, and how environments select for specific immune systems. In this issue, Meaden et al. [11] use metagenomics data analysis to determine how defence systems are distributed across different ecological niches, and how this covaries with the risk of phage infection. Silk et al. [12] use experimental evolution approaches to examine the impact of abiotic variables, such as salt concentrations, on the molecular evolution of phage resistance. Elliot et al. [13] examine how the protective ability of CRISPR-Cas immune systems varies depending on the phage and nutrient levels in the environment.

At a larger scale, defence systems may drive the evolution and epidemiology of bacterial pathogens. Blokesch [14] reviews the conserved defence mechanisms of the seventh pandemic El Tor (7PET) strain of Vibrio cholerae and their association with mobile genetic elements, and Blokesch & Seed [15] explain how coevolution between V. cholerae and its phage shapes cholera epidemiology. Le Roux [16] reviews how other Vibrio species can serve as powerful models to study the eco-evolutionary dynamics of bacteria and phage interactions and how bacterial defence systems are frequently moved around by mobile genetic elements themselves. Finally, Ojiogu et al. [17] describe strategies that mobile genetic elements can use to combat one another, identifying a novel mechanism used by Staphylococcus aureus pathogenicity islands to redirect helper phage capsid assembly. This highlights the key point of conflict between mobile genetic elements and how various mechanisms may have evolved not only to protect the bacterial hosts but also to outcompete other mobile genetic elements that can infect the same strain or species, a point that is further discussed in the perspective by Clabby et al. [6].

As the bacterial immune system landscape continues to expand, the field stands at an exciting and challenging juncture. We now face the dual tasks of filling in the mechanistic gaps in our understanding, while also zooming out to appreciate how these systems function and evolve within microbial ecosystems. This iscussion Meeting issue aims to contribute meaningfully to both of these goals.

Contributor Information

Edze Rients Westra, Email: e.r.westra@exeter.ac.uk.

Uri Gophna, Email: UriGo@tauex.tau.ac.il.

Stineke van Houte, Email: c.van-houte@exeter.ac.uk.

Ethics

This work did not require ethical approval from a human subject or animal welfare committee.

Data accessibility

This article has no additional data.

Declaration of AI use

We have not used AI-assisted technologies in creating this article.

Authors’ contributions

E.R.W.: writing—original draft, writing—review and editing; U.G.: writing—original draft, writing—review and editing; S.v.H.: writing—original draft, writing—review and editing.

All authors gave final approval for publication and agreed to be held accountable for the work performed herein.

Conflict of interest declaration

This theme issue was put together by the Guest Editor team under supervision from the journal’s Editorial staff, following the Royal Society’s ethical codes and best-practice guidelines. The Guest Editor team invited contributions and handled the review process. Individual Guest Editors were not involved in assessing papers where they had a personal, professional or financial conflict of interest with the authors or the research described. Independent reviewers assessed all papers. Invitation to contribute did not guarantee inclusion.

Funding

We acknowledge the Biotechnology and Biological Sciences Research Council award sLoLa BB/X003051/1 (to S.v.H. and E.R.W.)

References

  • 1. Barthes K, Rousset F, Wein T. 2025. Viral effectors trigger innate immunity across the tree of life. Phil. Trans. R. Soc. B 380, 20240077. ( 10.1098/rstb.2024.0077) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Koonce KC, Mauritzen J, Hitz IF, Vangsgaard EF, Putz EHM, Wajn AS, Leth FH, Høyland-Kroghsbo N. 2025. The H-NS homologues MvaT and MvaU repress CRISPR-Cas in Pseudomonas aeruginosa. Phil. Trans. R. Soc. B 380, 20240073. ( 10.1098/rstb.2024.0073) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Readshaw J, Lee YJ, Weigele P, Blower T. 2025. Modified DNA substrate selectivity by GmrSD-family type IV restriction enzyme BrxU. Phil. Trans. R. Soc. B 380, 20240072. ( 10.1098/rstb.2024.0072) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Belukhina . 2025. Specificity and mechanism of tRNA cleavage by the AriB Toprim nuclease of the PARIS bacterial immune system. Phil. Trans. R. Soc. B 380, 20240074. ( 10.1098/rstb.2024.0074) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Hoikkala V, Chi H, Grüschow S, Graham S, White M. 2025. Diversity and abundance of ring nucleases in type III CRISPR-Cas loci. Phil. Trans. R. Soc. B 380, 20240084. ( 10.1098/rstb.2024.0084) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Clabby T, Tesson F, Gaborieau B, Bernheim A. 2025. Why do bacteria accumulate antiphage defence systems? Phil. Trans. R. Soc. B 380, 20240082. ( 10.1098/rstb.2024.0082) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Kupczok A, Gavriilidou A, Paulitz E, Guerrero-García L, Baumdicker F. 2025. Gene co-occurrence and its association with phage infectivity in bacterial pangenomes. Phil. Trans. R. Soc. B 380, 20240070. ( 10.1098/rstb.2024.0070) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Pons B, Lapinska U, Lopes-Domingues I, Chisnall MAW, Westra ER, Pagliara S. 2025. Phage provoke growth delays and SOS response induction despite CRISPR-Cas protection. Phil. Trans. R. Soc. B 380, 20240474. ( 10.1098/rstb.2024.0074) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. David E, Plantady C, Poissonnier S, Elliott J, Kenck E, Le Boulch J, Gutierrez A, Chevallereau A. 2025. Systematic functional assessment of anti-phage systems in their native host. Phil. Trans. R. Soc. B 380, 20240067. ( 10.1098/rstb.2024.0067) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Czernuszka M, Fu T, Kottara A, Brockhurst M, Wright R. 2025. Bacteria-phage infection network structure and genomic defence system content predict efficacy of a phage therapy cocktail against Pseudomonas aeruginosa from chronic lung infections. Phil. Trans. R. Soc. B 380, 20240080. ( 10.1098/rstb.2024.0080) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Meaden S, Westra ER, Fineran P. 2025. Phage defence system abundances vary across environments and increase with viral density. Phil. Trans. R. Soc. B 380, 20240069. ( 10.1098/rstb.2024.0069) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Silk E, Harding K, Mahler M, Fineran P, Meaden S. 2025. Abiotic environmental conditions determine phage resistance outcomes in a salt-marsh bacterium. Phil. Trans. R. Soc. B 380, 20240071. ( 10.1098/rstb.2024.0071) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Elliot J, Cozens K, Cai Y, Waugh G, Watson BN, Westra ER, Taylor T. 2025. Phage susceptibility to a minimal, modular synthetic CRISPR-Cas system in Pseudomonas aeruginosa is nutrient-dependent. Phil. Trans. R. Soc. B 380, 20240473. ( 10.1098/rstb.2024.0473) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Blokesch M. 2025. Defence systems encoded by core genomic islands of seventh pandemic Vibrio cholerae. Phil. Trans. R. Soc. B 380, 20240083. ( 10.1098/rstb.2024.0083) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Blokesch M, Seed K. 2025. Lineage-specific defence systems of pandemic Vibrio cholerae. Phil. Trans. R. Soc. B 380, 20240076. ( 10.1098/rstb.2024.0076) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Le Roux F. 2025. The ecology and evolution of microbial immunes: a look on the wild Vibrio side. Phil. Trans. R. Soc. B 380, 20240078. ( 10.1098/rstb.2024.0078) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Ojiogu A, Patkowski J, Kuang X, Costa T, Rostøl J, Penades J. 2025. Capsid redirection mechanism of the Staphylococcus aureus pathogenicity island SaPIpT1028. Phil. Trans. R. Soc. B 380, 20240075. ( 10.1098/rstb.2024.0075) [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

This article has no additional data.


Articles from Philosophical Transactions of the Royal Society B: Biological Sciences are provided here courtesy of The Royal Society

RESOURCES